Olaparib 100mg comp
About This Opportunity
Award by Serviços de Saúde da Região Autónoma da Madeira (Portugal, healthcare): Olaparib 100mg comp. Awarded to ASTRAZENECA PRODUTOS FARMACEUTICOS (EUR 634K.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 105,658.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender pertains to the procurement of OLAPARIB 100mg compounding products in Portugal. OLAPARIB is an innovative pharmaceutical agent utilized primarily in the treatment of certain types of cancer, particularly those associated with BRCA mutations. The contracting authority, while not explicitly identified in the provided information, typically encompasses health ministries or public health organizations responsible for managing the procurement of essential medicines within the region.
The tender seeks qualified suppliers who can provide OLAPARIB in compliance with European and national regulatory standards.
Interested bidders should demonstrate their capability to deliver high-quality pharmaceutical products that meet stringent safety and efficacy requirements. Typical requirements for submission may include the provision of relevant licenses, certifications, and evidence of previous successful deliveries of similar pharmaceutical products. Suppliers will be expected to outline their capacity for consistent supply, adherence to manufacturing guidelines, and quality assurance processes.
Suppliers are encouraged to detail their distribution logistics, ensuring timely delivery to designated health facilities across Portugal. Additionally, considerations for competitive pricing, sustainability practices, and the ability to provide ongoing support and information on the product will be critical in the evaluation of bids.
This tender represents an opportunity for pharmaceutical companies to contribute to the healthcare landscape in Portugal, particularly in enhancing treatment options for patients affected by cancer. Interested parties should prepare comprehensive proposals that align with the outlined requirements and standards.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 11, 2026. Last refreshed 3 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) has issued 8 procurement notices on BidsFactory, including 0 currently open and 8 awarded contracts. Activity concentrates in Health & Medical. All notices are published for Portugal. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: June 17, 2026.
Frequently asked questions about this tender
How much was the contract awarded for?
ASTRAZENECA PRODUTOS FARMACEUTICOS, LDA was awarded the contract for €633,947. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to ASTRAZENECA PRODUTOS FARMACEUTICOS, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.